Physician profile
Ali Aboufares
NPI 1508837287
$145,286.25
in general payments reported to CMS, 2019-2025
43 companies · $32K in 2025
The $32K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $12K · 2021: $22K · 2022: $22K · 2023: $21K · 2024: $22K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $72K · Food and Beverage: $3,402 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $71,540.00 |
| Food and Beverage | $3,402.36 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $131,222.01 | 2019-2025 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Cardiovascular Systems INC. | $3,128.93 | 2019-2022 | |
| Boston Scientific Corporation | $1,619.20 | 2019-2025 | Varithena Administration Pack, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $1,033.12 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $929.77 | 2019-2024 | Xarelto |
| Amgen INC. | $851.65 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $668.44 | 2021-2025 | Jot Dx, Aveir |
| Medtronic Vascular, INC. | $653.96 | 2019-2020 | |
| Philips North America LLC | $521.40 | 2022-2024 | (5028) Igt Devices Systems Undivided |
| Medtronic, INC. | $467.99 | 2021-2024 | Hawkone, Venaseal |
| Astrazeneca Pharmaceuticals LP | $450.83 | 2021-2024 | Farxiga |
| Esperion Therapeutics, INC. | $420.87 | 2020-2022 | |
| Tactile Systems Technology INC | $385.00 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Pfizer INC. | $359.40 | 2019-2025 | |
| Terumo Medical Corporation | $343.14 | 2019-2023 | Metacross Otw, Angio-Seal, Azur Cx Detachable |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Aboufares listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.